Answers are grounded in this paper and cite their sources.
Background/Objectives: Duodenogastric reflux (DGR) gastritis remains a clinically challenging condition with limited comparative evidence regarding commonly used medical treatments and no well-established therapeutic strategy. This study aimed to compare symptomatic responses to different treatment regimens (PPI, PPI + sucralfate, PPI + UDCA) and to examine associations of gallbladder status with symptoms and histopathological findings in patients diagnosed with DGR. Methods: A total of 77 patients diagnosed with DGR in our endoscopy unit were retrospectively evaluated. Patients were divided into three groups: Group 1 (PPI + sucralfate, n = 32), Group 2 (PPI + UDCA, n = 31), and Group 3 (PPI, n = 14). Symptom scores were assessed before and after 6 weeks of treatment using a modified Likert scale. Histopathological parameters and symptoms were also evaluated according to gallbladder status (normal, gallstone, cholecystectomy). In 16 patients who underwent follow-up endoscopy, biopsy results before and after treatment were compared. Results: All three treatment groups showed significant within-group reductions in symptom scores after 6 weeks of therapy (all p < 0.01). However, the magnitude of symptom improvement did not differ significantly among treatment groups (p = 0.457). Symptom scores also decreased significantly within each gallbladder-status group, without a significant between-group difference. In the 16 patients with paired biopsies, no histopathological outcome showed a statistically significant change on two-sided exact Wilcoxon testing (activation p = 0.078; inflammation p = 0.094; intestinal metaplasia p = 0.625; H. pylori grade p = 0.307); these exploratory results were unadjusted for multiple comparisons. Conclusions: PPI, PPI + sucralfate, and PPI + UDCA regimens were each associated with significant short-term symptomatic improvement in patients with DGR; however, no statistically significant between-group difference was detected. Gallbladder status was not significantly associated with the magnitude of symptomatic improvement. The histopathological findings from the limited follow-up endoscopy subgroup should be interpreted as exploratory and require confirmation in larger prospective studies. By comparatively evaluating three commonly used medical treatment approaches together with gallbladder status within the same real-world cohort, this study provides additional clinical evidence in an area where comparative treatment data remain limited.
No takes yet. Share an insight, caveat, or question.
Yıldız et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: